Morfogen IVS: Financial statements 2018
CVR: 38471031
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
Morfogen IVS (CVR 38471031) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK -9,611 and a net result of DKK -9,757 compared with DKK -3,582 the year before. Equity in the 2018 report amounted to DKK -6,686.
- Gross Profit
- DKK -9,611
- Profit/Loss
- DKK -9,757
- Equity
- DKK -6,686
- Total Assets
- DKK 3,044
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | -10 t. | -10 t. | -7 t. | - |
| 2017 | - | -3 t. | -4 t. | -4 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
As of November 22, 2018, Pang Chi Kit is registered as director of Morfogen IVS.
As of November 22, 2018, Karsten Madsen has stepped down as liquidator of Morfogen IVS.
On November 22, 2018, Morfogen IVS exited liquidation.
As of September 6, 2018, Karsten Madsen is registered as liquidator of Morfogen IVS.
On September 6, 2018, Morfogen IVS entered liquidation.
As of August 26, 2018, Chi Kit Pang has stepped down as adm. dir. of Morfogen IVS.
About Morfogen IVS
Morfogen IVS was a Danish company of the type Iværksætterselskab based in Frederikshavn, founded in 2017. The company has been dissolved on 27 November 2019. The company was registered under the industry Tøjforretninger. In 2018, the company reported a gross profit of DKK -9,611 and a net result of DKK -9,757 compared with DKK -3,582 the year before. Equity in the 2018 report amounted to DKK -6,686.